Estimated reading time: 6 minutes Key Takeaways Trump’s tariffs have introduced new import taxes that are passed on to consumers, raising inflation concerns. Public scepticism about *controlling inflation* via tariffs …
-
-
Estimated reading time: 6 minutes Key Takeaways Nvidia stock saw a 20% drop early this year followed by a dramatic 52% surge. Geopolitical pressures from US-China trade tensions are reshaping …
-
Estimated reading time: 4 minutes Key Takeaways Cooper Companies’ shares fell by 14.64% to £68.25, well below its 52-week peak. A lowered organic growth forecast sparked investor concerns. Projected tariff …
-
Estimated reading time: 4 minutes Key Takeaways Wall Street’s optimism hinges on Dell’s rapidly growing AI server division. Mixed earnings are offset by a substantial $14.4 billion AI backlog. Major …
-
Estimated reading time: 5 minutes Key Takeaways Stock movers spotlight significant price changes that can signal new trends. Real-time data keeps investors ahead of rapid market developments. High trading volume …
-
Estimated reading time: 5 minutes Key Takeaways Tesla experiences its second consecutive winning month, climbing 52% since 9 April 2025. The stock currently trades above the 12-month consensus price target …
-
Estimated reading time: 6 minutes Key Takeaways Red Robin shares soared 75% after posting an unexpected Q1 2025 profit. Improved operational performance and lower costs contributed to the earnings surprise. …
-
Estimated reading time: 5 minutes Key Takeaways Trump’s allegations of a breached agreement by China heighten trade tension. Fears reignite over a potential escalation in the trade war. Wall Street …
-
Estimated reading time: 5 minutes Key Takeaways The Personal Consumption Expenditures (PCE) Price Index is the Fed’s primary inflation gauge, capturing a wide range of consumer spending. By excluding volatile …
-
Estimated reading time: 7 minutes Key Takeaways The experimental COPD drug itepekimab from Regeneron and Sanofi fails an important Phase 3 trial. Regeneron shares plunged by over 10%, and Sanofi …